| top | |
| BRAINLIFE NEWSLETTER | |
Volume 3, Number 4 - 9
February 2004 |
|
|
|
|
|
Contents |
|
|
|
|
| Etiology & Pathogenesis | |
| Treatment | |
|
|
|
|
|
|
|
|
|
|
Domenico Didiano, Tarek Shalaby, Doris Lang, Michael
A. Grotzer Telomere maintenance in childhood primitive neuroectodermal brain tumors Neuro-Oncology, Jan 2004, Volume 6 Number 1, Pages 1 -- 8 |
|
|
M.T. Giordana, C.
Ghimenti, E. Leonardo, I. Balteri, M. Iudicello, D. Duò Molecular Genetic Study of a Metastatic Oligodendroglioma Journal of Neuro-Oncology, 66 (3): 265-271, February 2004 |
|
|
Christian
Mawrin MD, Solveig Schulz MD, Steffen U. Pauli MD, Tim Treuheit MD,
Sabine Diete MD, Knut Dietzmann MD, Raimund Firsching MD, Stefan Schulz MD,
and Volker Höllt MD |
|
| Yeazel
MW, Oeffinger KC, Gurney JG, Mertens AC, Hudson MM, Emmons KM, Chen H,
Robison LL The cancer screening practices of adult survivors of childhood cancer Cancer. 2004 Feb 1;100(3):631-40 |
|
|
|
|
|
|
|
|
|
|
| Gross-Tsur
V, Shalev RS Reversible language regression as an adverse effect of topiramate treatment in children Neurology. 2004 Jan 27;62(2):299-300 |
|
|
Tracy T. Batchelor, Mark R. Gilbert, Jeffrey G. Supko, Kathryn A. Carson,
Louis B. Nabors, Stuart A. Grossman, Glenn J. Lesser, Tom Mikkelsen, and Surasak
Phuphanich |
|
|
Susan L. Chua, Mark A. Rosenthal, Shirley S. Wong, David
M. Ashley, Anne-marie Woods, Anthony Dowling, and Lawrence M. Cher Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme Neuro-Oncology, January 2004, Volume 6 Number 1, Pages 38 -- 43 |
|
|
Alf
Giese, Thomas Kucinski, Ulrich Knopp, Roland Goldbrunner, Wolfgang Hamel,
H.M. Mehdorn, Jörg
C. Tonn, Dana Hilt, Manfred
Westphal |
|
|
John J. Laterra, Stuart A.
Grossman, Kathryn A. Carson, Glenn J. Lesser, Fred H. Hochberg, Mark R.
Gilbert Suramin and radiotherapy in newly diagnosed glioblastoma: Phase 2 NABTT CNS Consortium study Neuro-Oncology, Jan 2004, Volume 6 Number 1, Pages 15 -- 20 |
|
| Mehta MP,
Shapiro WR, Glantz MJ, Patchell RA, Weitzner MA, Meyers CA, Schultz CJ, Roa WH,
Leibenhaut M, Ford J, Curran W, Phan S, Smith JA, Miller RA, Renschler MF Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points J Clin Oncol. 2002 Aug 15; 20(16): 3445-53 |
|
|
Michael D. Prados, W.K. Alfred Yung, Howard A. Fine,
Harry S. Greenberg, Larry Junck, Susan M. Chang, M. Kelly Nicholas, H. Ian
Robins, Minesh P. Mehta, Karen L. Fink, Kurt A. Jaeckle, John Kuhn,
Kenneth R. Hess, and S. Clifford Schold Jr. Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study Neuro-Oncology, January 2004, Volume 6 Number 1, Pages 33 -- 37 |
|
|
N.G.
Rainov, V. Heidecke |
|
|
Lisa
R. Rogers, Sandra E. Remer, Sheela Tejwani Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy 
Neuro-Oncology, January 2004, Volume 6 Number 1, Pages 63 -- 64 |
|
|
S. Clifford Schold Jr., Demetrius M. Kokkinakis,
Susan M. Chang, Mitchel S. Berger, Kenneth R. Hess, David Schiff, H. Ian
Robins, Minesh P. Mehta, Karen L. Fink, R.L. Davis, and Michael D. Prados O6-Benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas Neuro-Oncology, January 2004, Volume 6 Number 1, Pages 28 -- 32 |
|
|
Antonio
Silvani, Marica Eoli, Andrea Salmaggi, Elena Lamperti, Elio
Maccagnano, Giovanni Broggi, Amerigo Boiardi |
|
